Antiarrhythmic formulation
US11007185B2 · kind B2 · utility
1Cited by
37References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2020 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Jun 15, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.